Evidence map›Paper›PMID 22977278›Full record

Trial reportJournal of neurointerventional surgery2013

Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial.

Colin P Derdeyn, David Fiorella, Michael J Lynn, Stanley L Barnwell, Osama O Zaidat, Philip M Meyers, Y Pierre Gobin, Jacques Dion, Bethany F Lane, Tanya N Turan and 3 more

Registry-linked trialOpen access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of neurointerventional surgery, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00576693 (Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis), which is not on this map. Cited by 34 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 4 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00576693 phase3completednot on this map

Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis

TypeinterventionalSponsorMedical University of South CarolinaRan2008 to 2013Enrolled451ConditionsIschemic StrokeArmsintracranial angioplasty and stenting, intensive medical management
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 4 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Prevalence, prognosis, and treatment of atherosclerotic intracranial stenosis in Caucasians.International journal of stroke : official journal of the International Stroke Society · 2021
    Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 1 country.

Colin P DerdeynMallinckrodt Institute of Radiology and the Departments of Neurology and Neurosurgery, Washington University School of Medicine, St Louis, Missouri, USA.
David Fiorella
Michael J Lynn
Stanley L Barnwell
Osama O Zaidat
Philip M Meyers
Y Pierre Gobin
Jacques Dion
Bethany F Lane
Tanya N Turan
L Scott Janis
Marc I Chimowitz
SAMMPRIS Trial Investigators
Emory University · USMedical University of South Carolina · USColumbia University · USCornell University · USMallinckrodt (United States) · USMedical College of Wisconsin · USNational Institute of Neurological Disorders and Stroke · USOregon Health & Science University · USState University of New York · US

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
SAMMPRIS (Stenting vs. Aggressive Medical Management for Preventing . . .U01NS058728 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CHIMOWITZ, MARC IVOR · 2008 to 2011
$20.0M
P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI GEISERT, ELDON E · 1986 to 2025
$15.3M
UF CLINICAL AND TRANSLATIONAL SCIENCE AWARDUL1RR029890 · NCRR · UNIVERSITY OF FLORIDA · PI NELSON, DAVID R · 2009 to 2011
$14.4M
SOUTH CAROLINA CLINICAL & TRANSLATIONAL RESEARCH INSTITUTE (SCTR)UL1RR029882 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2009 to 2011
$10.1M
Cincinnati Center for Clinical and Translational Sciences and TrainingUL1TR000077 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E. · 2012 to 2014
$9.9M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR000062 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2012 to 2014
$9.4M
WARFARIN VS ASPIRIN FOR INTRACRANIAL ARTERIAL STENOSISR01NS036643 · NINDS · EMORY UNIVERSITY · PI CHIMOWITZ, MARC IVOR · 1998 to 2002
$9.1M
Coordinating Center for Infant Aphakia Treatment Study (IATS)U10EY013287 · NEI · EMORY UNIVERSITY · PI LONG, QI · 2004 to 2014
$5.8M
The Role of Cerebral Hemodynamics in Moya Moya DiseaseR01NS051631 · NINDS · WASHINGTON UNIVERSITY · PI DERDEYN, COLIN PIETER · 2006 to 2010
$1.6M
Coordinating Center for Infant Aphakia Treatment Study (IATS)UG1EY013287 · NEI · EMORY UNIVERSITY · PI NIZAM, AZHAR · 2015 to 2018
$917k
Characterization of Intracranial Atherosclerotic Stenosis Using HR MRIK23NS069668 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TURAN, TANYA N · 2011 to 2015
$903k
NCATS NIH HHS KL2 TR000060NCATS NIH HHS UL1 TR000062NCATS NIH HHS UL1 TR000077NCRR NIH HHS TL1 RR029889NCRR NIH HHS UL1 RR024131NCRR NIH HHS UL1RR024131NCRR NIH HHS UL1 RR029882NCRR NIH HHS UL1RR029882NCRR NIH HHS UL1RR029889NCRR NIH HHS UL1 RR029890NCRR NIH HHS UL1RR029890NEI NIH HHS EY006360NEI NIH HHS EY013287NEI NIH HHS P30 EY006360NEI NIH HHS U10 EY013287NEI NIH HHS UG1 EY013287NINDS NIH HHS 1 K23 NS069668-01A1NINDS NIH HHS 1 K24 NS050307NINDS NIH HHS 1 R01 NS36643NINDS NIH HHS K23 NS069668NINDS NIH HHS K24 NS050307NINDS NIH HHS R01 NS036643NINDS NIH HHS R01 NS051631NINDS NIH HHS R01 NS051688NINDS NIH HHS U01 NS058728PHS HHS P50 55977
6 · The paper itself

Abstract

background and purposeTo investigate the relationship between physician and site experience and the risk of 30 day hemorrhagic and ischemic strokes in the stenting arm of the Stenting and Aggressive Medical Management for the Prevention of Recurrent Ischemic Stroke (SAMMPRIS) trial.

methodsStudy records and an investigator survey were examined for physician and site related factors, including: number of Wingspan and aneurysm stents submitted for credentialing, number of study procedures performed in SAMMPRIS, years in practice after training, primary specialty, and site enrollment. Bivariate and multivariate analyses were performed to determine if these factors were associated with the 30 day rate of cerebrovascular events after angioplasty and stenting.

results213 patients underwent angioplasty alone (n=5) or angioplasty and stenting (n=208) with study devices by 63 interventionists at 48 sites. For credentialing, the median number of Wingspan and similar aneurysm stent cases submitted by study interventionists were 10 and 6, respectively. Interventionists with higher numbers (>10) of Wingspan cases submitted for credentialing tended to have higher rates of 30 day events (19.0% vs 9.9%) than those with <10 cases. High enrolling sites in the trial tended to have lower rates of hemorrhagic stroke (9.8% at sites enrolling <12 patients vs 2.7% at sites enrolling >12 patients).

conclusionsInterventionists credentialed with less Wingspan experience were not responsible for the high rate of periprocedural stroke in SAMMPRIS. Hemorrhagic stroke may be related to low enrollment in the trial but not previous Wingspan experience.

Indexed as

StentsAngioplastyBrain IschemiaCerebral HemorrhageCerebral InfarctionClinical CompetenceCredentialingFollow-Up StudiesHumansMultivariate AnalysisNeurosurgeryNeurosurgical ProceduresPatient SafetyPostoperative ComplicationsProspective StudiesSecondary PreventionAngioplastyStentStroke

Identifiers

PMID22977278
PMCPMC3652908
OpenAlexW2124077813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.